A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Chauhan, Ashwini ^a   Lebeaux, David ^a   Decante, Benoit ^b   Kriegel, Irene ^c   Escande, Marie Christine ^c   Ghigo, Jean Marc ^a   Beloin, Christophe ^a  

^a INSTITUT PASTEUR   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; GENTAMICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC LOCK THERAPY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BIOFILM; BIOLUMINESCENCE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DEATH; ESCHERICHIA COLI; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NON INVASIVE MEASUREMENT; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ANIMAL; CENTRAL VENOUS CATHETERIZATION; EQUIPMENT; ESCHERICHIA COLI INFECTION; GROWTH, DEVELOPMENT AND AGING; IMMUNOSUPPRESSIVE TREATMENT; INDWELLING CATHETER; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA; RATTUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CEFAZOLIN; EQUIPMENT CONTAMINATION; ESCHERICHIA COLI INFECTIONS; GENTAMICINS; IMMUNOSUPPRESSION; MALE; MODELS, ANIMAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84861209865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037281     Document Type: Article

References (46)

1. Hall-Stoodley L, Stoodley P, (2009) Evolving concepts in biofilm infections. Cellular Microbiology 11: 1034-1043.
2. Lynch AS, Robertson GT, (2008) Bacterial and fungal biofilm infections. Annu Rev Med 59: 415-428.
3. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O, (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35: 322-332.
4. Wagner C, Hänsch GM, Wentzensen A, Heppert V, (2006) Implant-associated post-traumatic osteomyelitis. Bacterial biofilms and the immune defence as protagonists of the local inflammatory process. Unfallchirurg 109: 761-769.
5. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, et al. (2010) Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 121: 458-477.
6. Mermel Leonard A, Allon M, Bouza E, Craven Donald E, Flynn P, et al. (2009) Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49: 1-45.
7. Console G, Calabro C, Nardulli P, Digiuseppe F, Rucci A, et al. (2007) Clinical and economic effects of central venous catheters on oncology patient care. J Chemother 19: 309-314.
8. Scott RD, (2009) The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. CDC pp. 1-16.
9. Coenye T, Nelis HJ, (2010) In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods 83: 89-105.
10. Donlan RM, (2011) Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clin Infect Dis 52: 1038-1045.
11. Francolini I, Donelli G, (2010) Prevention and control of biofilm based-medical device related infections. FEMS Immunology & Medical Microbiology pp. 1-12.
12. Simões M, (2011) Antimicrobial strategies effective against infectious bacterial biofilms. Curr Med Chem 18: 2129-2145.
13. Kadurugamuwa JL, Sin L, Albert E, Yu J, Francis K, et al. (2003) Direct continuous method for monitoring biofilm infection in a mouse model. Infection and Immunity 71: 882-890.
14. Vuong C, Kocianova S, Yu J, Kadurugamuwa Jagath L, Otto M, (2008) Development of Real-Time In Vivo Imaging of Device-Related Staphylococcus epidermidis Infection in Mice and Influence of Animal Immune Status on Susceptibility to Infection. J Infect Dis 198: 258-261.
15. Wang R, Khan BA, Cheung GYC, Bach T-HL, Jameson-Lee M, et al. (2011) Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J Clin Invest 121: 238-248.
16. Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Orlando F, et al. (2006) RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J Infect Dis 193: 180-186.
17. Fernández-Hidalgo N, Gavaldà J, Almirante B, Martín M-T, Onrubia PL, et al. (2010) Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection. J Antimicrob Chemother 65: 525-530.
18. Rupp ME, Ulphani JS, Fey PD, Mack D, (1999) Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infection and Immunity 67: 2656-2659.
19. Van Praagh AD, Li T, Zhang S, Arya A, Chen L, et al. (2011) Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrobial agents and chemotherapy 55: 4081-4089.
20. Maki DG, Kluger DM, Crnich CJ, (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81: 1159-1171.
21. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, et al. (1987) Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 147: 873-877.
22. Ramphal R, Balloy V, Jyot J, Verma A, Si-Tahar M, et al. (2008) Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol 181: 586-592.
23. Bernier C, Gounon P, Le Bouguenec C, (2002) Identification of an aggregative adhesion fimbria (AAF) type III-encoding operon in enteroaggregative Escherichia coli as a sensitive probe for detecting the AAF-encoding operon family. Infection and immunity 70: 4302-4311.
24. Foucault M-L, Thomas L, Goussard S, Branchini BR, Grillot-Courvalin C, (2010) In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice. Applied and Environmental Microbiology 76: 264-274.
25. Fätkenheuer G, Buchheidt D, Cornely OA, Fuhr H-G, Karthaus M, et al. (2003) Central venous catheter (CVC)-related infections in neutropenic patients-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82 (Suppl 2): S149-157.
26. Tavares E, Maldonado R, Ojeda ML, Miñano FJ, (2005) Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats. Clin Diagn Lab Immunol 12: 1085-1093.
27. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ, (1988) Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 12: 185-189.
28. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, et al. (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92: 706-712.
29. Raad I, (1998) Intravascular-catheter-related infections. Lancet 351: 893-898.
30. Kokai-Kun JF, Chanturiya T, Mond JJ, (2009) Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice. J Antimicrob Chemother 64: 94-100.
31. Lorenz U, Hüttinger C, Schäfer T, Ziebuhr W, Thiede A, et al. (2008) The alternative sigma factor sigma B of Staphylococcus aureus modulates virulence in experimental central venous catheter-related infections. Microbes Infect 10: 217-223.
32. Kadurugamuwa JL, Francis KP, (2008) Bioluminescent imaging of bacterial biofilm infections in vivo. Methods Mol Biol 431: 225-239.
33. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, et al. (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119: 1168-1174.
34. Fallat ME, Gallinaro RN, Stover BH, Wilkerson S, Goldsmith LJ, (1998) Central venous catheter bloodstream infections in the neonatal intensive care unit. Journal of Pediatric Surgery 33: 1383-1387.
35. CDC (1998) National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. American Journal of Infection Control 26: 522-533.
36. Chang L, Tsai J-S, Huang S-J, Shih C-C, (2003) Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 31: 34-39.
37. Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW, (2002) Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect 45: 47-53.
38. Hanna H, Afif C, Alakech B, Boktour M, Tarrand J, et al. (2004) Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 25: 646-649.
39. Seifert H, (1997) Catheter-related Infections. Catheter-related infections due to gram-negative bacilli In: Seifert H, Jansen B, Farr BM, editors. New York Marcel Dekker pp. 255-284.
40. Astagneau P, Maugat S, Tran-Minh T, Douard M-C, Longuet P, et al. (1999) Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infection control and hopsital epidemiology 20: 494-498.
41. Casey AL, Mermel LA, Nightingale P, Elliott TSJ, (2008) Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 8: 763-776.
42. Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ, et al. (2005) Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 242: 193-200.
43. del Pozo JL, Serrera A, Martinez-Cuesta A, Leiva J, Penades J, et al. (2006) Biofilm related infections: is there a place for conservative treatment of port-related bloodstream infections? Int J Artif Organs 29: 379-386.
44. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, et al. (2006) Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57: 1172-1180.
45. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE, (2005) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55: 90-94.
46. Fowler VG, Justice A, Moore C, Benjamin DK, Woods CW, et al. (2005) Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 40: 695-703.